Holding(s) in Company
November 20 2008 - 10:02AM
UK Regulatory
RNS Number : 6139I
Protherics PLC
20 November 2008
Protherics PLC
Notification of Major Interests in Shares
London, UK; Brentwood, TN, US: 20 November 2008 - Protherics PLC ("Protherics" or the "Company"), the international biopharmaceutical
company focused on critical care and cancer, announces that, on 19 November 2008, in accordance with the Transparency Obligations Directive,
a notification of interest in the ordinary share capital of the Company was received from AXA Investment Managers UK Limited on behalf of
AXA S.A. and its Group Companies ("AXA"). Details of the interest notified are set out below.
1. Reason for the notification (please tick the
appropriate box or boxes)
An acquisition of voting rights X
An acquisition or disposal of financial instruments
which may result in the acquisition of shares
already issued to which voting rights are attached
An event changing the breakdown of voting rights
Other (please specify)
2. Full name of person(s) AXA S.A., 25 Avenue Matignon, 75008 Paris
subject to the notification and its group of companies.
obligation:
3. Full name of shareholder(s)
(if different from 2.):
4. Date of the transaction 18 November 2008
(and date on which the
threshold is crossed or
reached if different):
5. Date on which issuer 19 November 2008
notified:
6. Threshold(s) that is/are 12%
crossed or reached:
7. Notified details:
A: Voting rights attached to shares
Class/type of shares Situation previous to the Triggering Resulting situation after the triggering transaction
if possible using the ISIN transaction
CODE
Number of Shares Number of Voting Number of shares Number of voting % of voting
Rights rights rights
Direct Direct Indirect Direct Indirect
0702920 42,026,712 42,026,712 1,041,666 1,041,666 41,322,546 0.30% 11.79%
B: Financial Instruments
Resulting situation after the triggering transaction
Type of financial instrument Expiration date Exercise/ Conversion Number of voting % of voting rights
Period/ Date rights that may be
acquired if the
instrument is
exercised/
converted.
Total (A+B)
Number of voting rights % of voting rights
42,364,212 12.09%
8. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable
:
Name of Company/Fund Number of Shares % of issued share capital
AXA 716,666 0.20451
Direct
AXA Framlington 41,322,546 11.79204
Indirect
AXA IM UK 325,000 0.09274
Direct
Total Direct 1,041,666 0.29726
Total Indirect 41,322,546 11.79204
TOTAL 42,364,212 12.08930
Proxy Voting:
9. Name of the proxy holder:
10. Number of voting rights proxy holder will cease
to hold:
11. Date on which proxy holder will cease to hold
voting rights:
12. Additional information:
| Ends |
For further information please contact:
Protherics
Nick Staples, Director of Corporate Affairs +44 (0) 7919 480510
Julie Vickers, Company Secretary +44 (0)1928 518010
Financial Dynamics - press enquiries
London: Ben Atwell, Lara Mott +44 (0) 20 7831 3113
New York: John Capodanno +1 212 850 5600
Or visit www.protherics.com
This information is provided by RNS
The company news service from the London Stock Exchange
END
HOLQBLFLVFBBFBB
Protherics (LSE:PTI)
Historical Stock Chart
From Jun 2024 to Jul 2024
Protherics (LSE:PTI)
Historical Stock Chart
From Jul 2023 to Jul 2024
Real-Time news about Protherics (London Stock Exchange): 0 recent articles
More Protherics Plc News Articles